Robert E Ware
Overview
Explore the profile of Robert E Ware including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
243
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ingbritsen J, Callahan J, Morgan H, Munro M, Ware R, Hicks R
Cancer Imaging
. 2025 Jan;
25(1):7.
PMID: 39881380
True total-body and extended axial field-of-view (AFOV) PET/CT with 1m or more of body coverage are now commercially available and dramatically increase system sensitivity over conventional AFOV PET/CT. The Siemens...
2.
Thomas S, Callahan J, Conway P, Moon D, Morgan H, Ingbritsen J, et al.
Eur Urol Open Sci
. 2024 Dec;
71:49-56.
PMID: 39720335
Background And Objective: Although prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) has impacted the investigation and management of biochemical recurrence (BCR) of prostate cancer, negative scans are common...
3.
Hicks R, Ware R, Callahan J
Semin Nucl Med
. 2024 Sep;
55(1):11-20.
PMID: 39289090
PET/CT devices with an axial field-of-view (FOV) of 1 m allow simultaneous imaging from the head to the upper thighs, the typical axial extent of many "whole-body" oncological studies acquired...
4.
Ware R, Williams S, Hicks R
Semin Nucl Med
. 2019 Jun;
49(4):280-293.
PMID: 31227051
Although bone-scanning agents remain important for the detection of bone metastasis, the most common site of distant disease in prostate cancer, novel molecular imaging techniques are entering into clinical practice...
5.
Hicks R, Jackson P, Kong G, Ware R, Hofman M, Pattison D, et al.
J Nucl Med
. 2018 Nov;
60(6):777-785.
PMID: 30442752
Imaging of somatostatin receptor expression is an established technique for staging of neuroendocrine neoplasia and determining the suitability of patients for peptide receptor radionuclide therapy. PET/CT using Ga-labeled somatostatin analogs...
6.
7.
Vivash L, Gregoire M, Lau E, Ware R, Binns D, Roselt P, et al.
J Nucl Med
. 2013 Jul;
54(8):1270-7.
PMID: 23857513
Unlabelled: Studies report that (11)C-flumazenil (FMZ) PET more specifically localizes the epileptogenic zone in patients with medically refractory focal epilepsy than (18)F-FDG PET. However, practical aspects of (11)C use limit...
8.
9.
Hicks R, Ware R, Hofman M
J Nucl Med
. 2012 Oct;
53(11):1820-2.
PMID: 23035129
No abstract available.
10.
Ware R, Hicks R
J Nucl Med
. 2011 Dec;
52 Suppl 2:64S-73S.
PMID: 22144557
Health technology assessment (HTA) has the objective of providing individual patients, clinicians, and funding bodies with the highest-quality information on the net patient benefits and cost effectiveness of medical interventions....